Hypofractionated radiotherapy for breast cancer acceleration of the START A treatment regime: intermediate tolerance and efficacy

The purpose of this research was to conduct a prospective evaluation of accelerated hypofractionated radiotherapy in breast cancer patients treated with 41.6Gy in 13 fractions plus boost delivered five times a week.

7th Space